£20.0M
The oversubscribed round included backing from Molten Ventures, Morningside, DCVC, Cambridge Consultants, Civilization Ventures and Providence.
E
Evonetix
Evonetix builds semiconductor technology platforms for desktop DNA synthesis.
£20.0MTotal raised
Evonetix develops semiconductor technology applied to DNA synthesis, offering a benchtop platform for accurate gene assembly. The firm uses a silicon chip to control synthesis across thousands of reaction sites.
Categories
Team
CM
Colin McCracken
Chief Executive Officer
PB
Paul Beastall
Chair of the Board of Directors